Technology
Health
Medical

Neuronetics

648

$1.42
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.13 (-8.44%) Today
+$0.01 (+0.71%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell Neuronetics and other stocks, options, ETFs, and crypto commission-free!

About STIM

Neuronetics, Inc. commercial stage medical technology company. It focuses on designing, developing and marketing products for the patients suffering from psychiatric disorders. Read More The firm offers NeuroStar TMS, a therapy system for the treatment of major depressive disorders in adult patients. It also provides a range of support services, including patient education, practice data management system, and customer and technical services to help the client start and manage TMS therapy systems. The company was founded by Steven B. Waite, Bruce J. Shook, Norman R. Weldon and Thomas D. Weldon in April 2003 and is headquartered in Malvern, PA.

CEO
Christopher A. Thatcher
Employees
235
Headquarters
Malvern, Pennsylvania
Founded
2003
Market Cap
30.25M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
636.83K
High Today
$1.58
Low Today
$1.39
Open Price
$1.56
Volume
203.94K
52 Week High
$17.76
52 Week Low
$1.25

Collections

Technology
Health
Medical
Therapy
Advertising and Marketing
Education
Business Services
2018 IPO

STIM News

BenzingaMar 30

Neuronetics Recognized as 2020 Top Neurology Device Provider

Company acknowledged on Top 10 List by MedTech Outlook Magazine MALVERN, Pa., March 30, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial
35

STIM Earnings

-$0.84
-$0.56
-$0.28
-$0.00
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Expected May 5, Pre-Market

People Also Bought

Aurora Cannabis

870,046

$0.8096

-2.84%

Aurora Cannabis

870,046

$0.8096

-2.84%

Ford

672,376

$4.22

-3.21%

Ocugen, Inc

15,563

$0.2807

+0.25%

TherapeuticsMD

17,294

$0.9101

-8.92%

You May Also Like

RF-B
VUSE
SBS
SNDE
OUT
SILJ
EPAM
NAC
NEWA
OBCI
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy STIM

Market Price$1.42
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell Neuronetics stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up